Assay reproducibility and within-person variation of Müllerian inhibiting substance
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 94 (1) , 301-304
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30CA006927)
- National Institutes of Health (P50CA083638)
This publication has 16 references indexed in Scilit:
- Ovarian reserve evaluation: state of the artJournal of Assisted Reproduction and Genetics, 2008
- The Anti-Mullerian hormone and ovarian cancerHuman Reproduction Update, 2007
- Serum anti-Mullerian hormone throughout the human menstrual cycleHuman Reproduction, 2006
- Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal womenFertility and Sterility, 2005
- High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular statusHuman Reproduction, 2005
- Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal studyFertility and Sterility, 2005
- Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndromeHuman Reproduction, 2005
- Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertilityHuman Reproduction, 2004
- Antimüllerian hormone serum levels: a putative marker for ovarian agingFertility and Sterility, 2002
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000